Bispecific antibody constructs and methods of use
US11339221B2 · kind B2 · utility
0Cited by
7References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 30, 2018 |
| Grant date | May 24, 2022 |
| Priority date | — |
| Expiry date | Oct 30, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to bispecific antibody constructs that specifically bind both integrin alpha-V and integrin α5 (e.g., α5β1) and methods of making and using those constructs to treat cancer or other pathological conditions involving these integrins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.